Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
29 |
|
Actual shortage: | 11 (38%) | |
Anticipated shortage: | 1 (3%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 17 (59%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
1 (3%) |
|
Overdue reports |
5 (42%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAT-ERLOTINIB | 25MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129536 |
NAT-ERLOTINIB | 100MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129550 |
NAT-ERLOTINIB | 150MG | TABLET | Actual shortage | 2020-12-03 | 2024-02-02 | 129553 |
NAT-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-04-29 | 2024-06-12 | 226575 |
NAT-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2024-04-30 | 226579 |
NAT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2024-04-30 | 226582 |
NAT-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-06-13 | 2024-06-14 | 230400 |
NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67512 |
NAT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67515 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0